Cargando…
Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression
Although potent androgen receptor pathway inhibitors (ARPI) improve overall survival of metastatic prostate cancer patients, treatment-induced neuroendocrine prostate cancer (t-NEPC) as a consequence of the selection pressures of ARPI is becoming a more common clinical issue. Improved understanding...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438622/ https://www.ncbi.nlm.nih.gov/pubmed/28427194 http://dx.doi.org/10.18632/oncotarget.15854 |